TY - JOUR
T1 - Comparative efficacy of conservative, hyperbaric oxygen, and endovascular retinal surgery approaches in central retinal artery occlusion
AU - Akai, Ryota
AU - Ishida, Masaaki
AU - Ueda-Consolvo, Tomoko
AU - Hayashi, Atsushi
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature B.V. 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Purpose: To assess and compare the efficacy of three treatment modalities for central retinal artery occlusion (CRAO): conservative therapy, hyperbaric oxygen therapy (HBOT), and endovascular retinal surgery (ERS). Patients and methods: We retrospectively analyzed the cases of CRAO patients treated at the Toyama University Hospital. Their age range was 44–87 years; a balanced gender distribution was observed. The conservative therapy group included 13 eyes (6 males, 7 females, average age 74 years). HBOT group: 11 eyes from 10 patients (5 males, 5 females, average age 70 years). ERS group: 10 eyes (7 males, 3 females, average age 74 years). The treatments were as follows. Conservative group: ocular massage and sublingual nitroglycerin. HBOT: 60-min sessions at 2 atmospheres. ERS: vitrectomy followed by tissue plasminogen activator injection using a 47-ga. microneedle. Visual acuity was assessed using logMAR units, with statistical analyses by paired t-test, Kruskal–Wallis test, and Mann–Whitney U-test with Bonferroni correction. Results: The conservative group showed a slight visual acuity change from 1.96 ± 0.53 to 1.88 ± 0.56 (p = 0.56). The HBOT group exhibited a significant improvement from 1.79 ± 0.80 to 1.28 ± 0.81 (p = 0.007). The ERS group displayed the most substantial improvement, with scores moving from 1.98 ± 0.36 to 0.68 ± 0.49 (p = 0.0000413). The ERS group’s outcomes were significantly superior to those of the other groups. Conclusion: These results suggest that while conservative treatment may not be sufficient, both HBOT and endovascular retinal surgery show promise, with the latter demonstrating the most significant improvement.
AB - Purpose: To assess and compare the efficacy of three treatment modalities for central retinal artery occlusion (CRAO): conservative therapy, hyperbaric oxygen therapy (HBOT), and endovascular retinal surgery (ERS). Patients and methods: We retrospectively analyzed the cases of CRAO patients treated at the Toyama University Hospital. Their age range was 44–87 years; a balanced gender distribution was observed. The conservative therapy group included 13 eyes (6 males, 7 females, average age 74 years). HBOT group: 11 eyes from 10 patients (5 males, 5 females, average age 70 years). ERS group: 10 eyes (7 males, 3 females, average age 74 years). The treatments were as follows. Conservative group: ocular massage and sublingual nitroglycerin. HBOT: 60-min sessions at 2 atmospheres. ERS: vitrectomy followed by tissue plasminogen activator injection using a 47-ga. microneedle. Visual acuity was assessed using logMAR units, with statistical analyses by paired t-test, Kruskal–Wallis test, and Mann–Whitney U-test with Bonferroni correction. Results: The conservative group showed a slight visual acuity change from 1.96 ± 0.53 to 1.88 ± 0.56 (p = 0.56). The HBOT group exhibited a significant improvement from 1.79 ± 0.80 to 1.28 ± 0.81 (p = 0.007). The ERS group displayed the most substantial improvement, with scores moving from 1.98 ± 0.36 to 0.68 ± 0.49 (p = 0.0000413). The ERS group’s outcomes were significantly superior to those of the other groups. Conclusion: These results suggest that while conservative treatment may not be sufficient, both HBOT and endovascular retinal surgery show promise, with the latter demonstrating the most significant improvement.
KW - Central retinal artery occlusion
KW - Conservative treatment
KW - Endovascular retinal surgery
KW - Hyperbaric oxygen
UR - http://www.scopus.com/inward/record.url?scp=85209476145&partnerID=8YFLogxK
U2 - 10.1007/s10792-024-03335-y
DO - 10.1007/s10792-024-03335-y
M3 - 学術論文
C2 - 39521754
AN - SCOPUS:85209476145
SN - 0165-5701
VL - 44
JO - International Ophthalmology
JF - International Ophthalmology
IS - 1
M1 - 419
ER -